We would love to hear your thoughts about our site and services, please take our survey here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Added to my list -
Imec announced that it has started developing a groundbreaking SARS-CoV-2 test
to identify SARS-CoV-2 virus particles in a person’s exhaled breath
- aiming to have a functional prototype ready to test summer 2021
Thanks Trillsg :-)
Canterbury-based techn firm Ancon Medical announced the trial of its Nanotechnology
Biomarker Tagging (NBT) system, to provide a breath test to diagnose Coronavirus.
"Ashford and St Peter’s Hospitals NHS Foundation Trust has started trials for a new test which could
tell if a person has coronavirus in as little as 10 minutes.
The new test, developed by ANCON Medical, would require the patient to breathe into a mouthpiece for
one minute so that a sample of the chemicals in their breath can be collected.
These chemicals are then analysed by a supercomputer and compared to those found in the breath of
infected patients. A swab test is also done to provide a cheek sample"
- doesn't sound like a scalable test
Northumbria University, Newcastle has secured regional support and funding for the next stage of development
of a breath test
"All patients have to do is breathe into the device, which is similar to a breathalyser, and it will retrieve
biomarkers such as DNA and proteins in the breath which have diagnostic potential for diseases of the lung
and beyond"
"He said that he believes the device could work in a way that sees people take tests on their doorstep and
upload the results to "a cloud" (cloud computing)"
"We would like to see somebody have this box at home, and they just provide a sample, the driver picks it
up from them", and the sample is put in the machine in the van, then "the cloud" says what's there, he said.
"That's the ideal scenario."
- still in development, and doesn't sound very well thought through
Canary Health Tech - COVID19 RT-BAP is currently in late-stage development and is entering multiple
clinical trial studies in Q3 2020.
"The Johannesburg study (patient study size - 150) will map the COVID19 signature bio-pattern and
evaluate the implementation of Canary’s investigational test and RT-BAP platform designed to detect
COVID19 positive patients through a single breath test"
- still in development
Does anyone else have any research on other breath tests in development?
If we're at phase 3 trials now with results due year end...will Deepverge be first to market with
a covid breath test?
Thanks very much Atlantic :-)
It's a fascinating period of time we're all living through at the moment, and I'm genuinely excited about the innovations
and changes that are happening that could ultimately make the world a better place. It's definitely an exciting period for
Deepverge ...Labskin, Microtox PD and Microtox BT are all game changing solutions with huge potential!
I do admit to leaning towards the positive side of interpretation...but the basis for that positive outlook is
following obsessive research! (I do advise everyone to do their own though!)
I've been trying to find and research competitors that are operating in the same areas as Deepverge...and i'm
struggling! to either find any, or find any that are as good, or that offer anything even close to the complete
end to end solutions that DV have on the table.
I'd welcome comments from anyone else who knows the water monitoring side better - are there any other companies
out there who have anything like Microtox PD?
Labskin - worlds FIRST remote clinical skin trials platform.
Microtox BT -
There are various rapid tests being developed - how many are Breath Tests? Not nose swabs or blood samples,
but a rapid covid breathalyser?
From what I've been able to find...
Cleveland Clinic and Astrotech announced they are developing a Rapid COVID-19 Breath Test
"The goal of the partnership is to develop a device that will identify COVID-19 strains
using breath samples"
- early stages of development, clinical trial months away
Breathonix Pte Ltd, a spin-off company from the National University of Singapore (NUS),
has developed a breath test to detect COVID-19
"A person only needs to blow into a disposable mouthpiece connected to a high-precision breath sampler.
The exhaled breath is collected and fed into a cutting-edge mass spectrometer for measurement. A machine
learning software analyses the VOC profile and generates the result in less than a minute"
- clinical trial ongoing, and more tests are required to further improve the accuracy of the technology
Israeli merged companies NextGen Biomed and Scentech announced it has successfully identified a number
of initial indicators of biological markers that could allow it to map traces of COVID-19 in the
breath and lead to the creation of a breathalyser test to identify the virus.
- still in development stage
BumbleHum . Always nice to read your thoughtful and well reasoned posts. We all have to play the interpretation game to a degree and naturally , as shareholders, lean towards the positive side ( most of us that is ).
What is obvious is that this is an extremely exiting period for Deepverge and it’s associated partners. So much going on it’s hard to keep up. I think the smoke will start clearing after the 3rd November and obviously pending positive news from the much anticipated test results in Aberdeen we can look forward to a flurry of positive RNS announcements.